医学
曲普瑞林
子宫内膜异位症
戈塞雷林
布塞林
达那唑
左炔诺孕酮
促性腺激素释放激素
不利影响
促性腺激素释放激素激动剂
激素
妇科
泌尿科
内科学
促黄体激素
乳腺癌
癌症
人口
兴奋剂
计划生育
受体
环境卫生
研究方法
作者
Julie Brown,Cindy Farquhar
出处
期刊:JAMA
[American Medical Association]
日期:2015-01-20
卷期号:313 (3): 296-296
被引量:89
标识
DOI:10.1001/jama.2014.17119
摘要
What treatments are associated with improved outcomes for women with endometriosis?The levonorgestrel-releasing intrauterine system (LNG-IUD), gonadotropin-releasing hormone analogues (GnRHa; nafarelin, leuprolide, buserelin, goserelin, triptorelin), laparoscopic ablation, and excision are associated with relief of pain due to endometriosis. Gonadotropin-releasing hormone analogues and laparoscopic ablation or excision are associated with increased clinical pregnancy rates in women with endometriosis. Gonadotropin-releasing hormone analogues, danazol, and depot progestagens are associated with a higher incidence of adverse events.
科研通智能强力驱动
Strongly Powered by AbleSci AI